US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

279.02

-14.0500-4.79%

Pre-market: 281.952.93+1.05%04:06 EDT

Volume:250.25K

Turnover:71.54M

Market Cap:523.02M

PE:- -

High:297.75

Open:287.50

Low:278.70

Close:293.07

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.83

T/O Rate:13.35%

Dividend:1.00

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care Roundup: Market Talk

Table: CHC Healthcare Group Aug Rev Nt$327.6m vs Nt$283.8m

Seikagaku Faces FDA Setback on SI-6603 but No New Trials Required

Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA

Private Equity Firm TPG Explores Sale of Healthcare Software Company Lyric, Potential Valuation at $5 Billion

Top Executive Makes Bold Move With Major Healthcare Realty Trust Stock Sale

Ramsay Health Care (RMSYF) Gets a Hold from Citi

Citi Remains a Hold on Sonic Healthcare Limited (SHL)

EBOS Group Limited (EBO) Gets a Buy from Citi

Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Citi

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating

Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment

Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress

Sector Update: Healthcare

MT Newswires Live

Worldwide Healthcare Trust Tightens Capital Base With Share Buyback

Health Care Roundup: Market Talk

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/LABU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":279.02,"timestamp":1788984000000,"preClose":293.07,"halted":0,"volume":250247,"hourTrading":{"tag":"盘前","latestPrice":281.95,"preClose":279.02,"latestTime":"04:06 EDT","volume":146,"amount":41081.5749,"timestamp":1789027590050,"change":2.93,"changeRate":0.010501,"amplitude":0.00982},"delay":0,"changeRate":-0.047940765004947664,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Pre-Mkt","change":-14.05,"latestTime":"09-10 04:45:07 EDT","open":287.5,"high":297.75,"low":278.7,"amount":71541788.5209,"amplitude":0.065002,"askPrice":283.5,"askSize":5,"bidPrice":277.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789047000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":292.443,"aum":548181239.8,"dividendRate":0.0036,"bidAskSpread":0.003029,"preHourTrading":{"tag":"盘前","latestPrice":281.95,"preClose":279.02,"latestTime":"04:06 EDT","volume":146,"amount":41081.5749,"timestamp":1789027590050,"change":2.93,"changeRate":0.010501,"amplitude":0.00982},"postHourTrading":{"tag":"盘后","latestPrice":278.58,"preClose":279.02,"latestTime":"19:59 EDT","volume":5408,"amount":1506106.6336,"timestamp":1788998373887,"change":-0.44,"changeRate":-0.001577,"amplitude":0.005304},"volumeRatio":0.8340404567238816,"impliedVol":0.9225,"impliedVolPercentile":0.544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8340404567238816,"shares":1874486,"dividePrice":1.0045,"high":297.75,"amplitude":0.065002,"preClose":293.07,"low":278.7,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":279.02,"committee":0.95122,"eps":0,"divideRate":0.0036,"volume":250247,"delay":0,"ttmEps":0,"open":287.5,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":300.7,"twentyDayClose":280.67,"sixtyDayClose":178.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666566559","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666566559?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:20","pubTimestamp":1789028400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0608 GMT - CSPC Pharmaceutical's coming clinical data presentati","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4588","LABU","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666632495","title":"Table: CHC Healthcare Group Aug Rev Nt$327.6m vs Nt$283.8m","url":"https://stock-news.laohu8.com/highlight/detail?id=2666632495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666632495?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:35","pubTimestamp":1789025700,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","XBI","BK4581","XLV","HCSG","BK4137","LU0128526141.USD","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057563","title":"Seikagaku Faces FDA Setback on SI-6603 but No New Trials Required","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057563?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:23","pubTimestamp":1789025015,"startTime":"0","endTime":"0","summary":"The latest update is out from Seikagaku ( ($JP:4548) ). Seikagaku has received a complete response letter from the U.S. FDA regarding its biologics...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seikagaku-faces-fda-setback-on-si-6603-but-no-new-trials-required?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seikagaku-faces-fda-setback-on-si-6603-but-no-new-trials-required?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666955046","title":"Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666955046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666955046?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:03","pubTimestamp":1789020181,"startTime":"0","endTime":"0","summary":"Ascelia Pharma AB ( ($SE:ACE) ) has issued an update. Ascelia Pharma has completed a Type A meeting with the U.S. Food and Drug Administration to d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-holds-fda-type-a-meeting-on-orviglance-nda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-holds-fda-type-a-meeting-on-orviglance-nda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGXZ58947870.SGD","LU0516423174.USD","LU0499858438.USD","BK4085","BK4554","SG9999002604.SGD","LU1242518931.SGD","IE0031814969.USD","BK4220","LU0516422952.EUR","LU0261945553.USD","LU1861217088.USD","LU0823038988.USD","LU2543165471.USD","SG9999013478.USD","LABU","SG9999013460.SGD","LU0289960550.SGD","SE","LU0516422366.SGD","IE0034224299.USD","LU0589944569.HKD","LU2152927971.USD","FDNI","LU0516423091.SGD","LU2360107671.USD","IE0001KFT4U8.USD","BK4588","BK4581","BK4551","LU0264606111.USD","SG9999005177.SGD","BK4503","IE00BD6J9T35.USD","LU1861220207.SGD","BK4548","LU2125910500.SGD","LU0048573645.USD","LU0072462343.USD","LU2065171311.SGD","LU2125910849.SGD","LU0251143029.SGD","LU0345775950.USD","SG9999001135.SGD","SG9999002414.USD","LU1770036033.HKD","LU0572940350.SGD","LU0499858602.USD","LU1242518857.USD","LU0532188223.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124904281","title":"Private Equity Firm TPG Explores Sale of Healthcare Software Company Lyric, Potential Valuation at $5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1124904281","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124904281?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:54","pubTimestamp":1789008858,"startTime":"0","endTime":"0","summary":"Private equity firm TPG is reportedly exploring the sale of Lyric, a healthcare software company, according to sources familiar with the matter. The company generates approximately $250 million in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUYO","BK4550","BK4588","PSP","BK4581","CGVV","VHT","XBI","PRVT","AAUM","IGM","BK4585","XLV","NOBL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666551904","title":"Top Executive Makes Bold Move With Major Healthcare Realty Trust Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666551904","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666551904?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:07","pubTimestamp":1789006073,"startTime":"0","endTime":"0","summary":"New insider activity at Healthcare Realty Trust ( ($HR) ) has taken place on September 9, 2026. Healthcare Realty Trust’s Executive Vice President ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-healthcare-realty-trust-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-healthcare-realty-trust-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","XLV","BK4581","XBI","LABU","LU0128526141.USD","LU0029874061.USD","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559343","title":"Ramsay Health Care (RMSYF) Gets a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559343?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:05","pubTimestamp":1789002342,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Sutcliffe from Citi maintained a Hold rating on Ramsay Health Care, with a price target of A$49.00. Sutcliffe cov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4185","BK4585","BK4581","LABU","BK4588","RMSYF","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559315","title":"Citi Remains a Hold on Sonic Healthcare Limited (SHL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559315?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:05","pubTimestamp":1789002338,"startTime":"0","endTime":"0","summary":"Citi analyst Laura Sutcliffe maintained a Hold rating on Sonic Healthcare Limited today and set a price target of A$22.00. According to TipRanks, S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","XLV","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666556378","title":"EBOS Group Limited (EBO) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666556378","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666556378?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:35","pubTimestamp":1789000522,"startTime":"0","endTime":"0","summary":"Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50. Sutcliffe covers the Healthcare...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ebos-group-limited-ebo-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ebos-group-limited-ebo-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555425","title":"Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555425?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:05","pubTimestamp":1788998756,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited received a Buy rating and price target from Citi analyst Laura Sutcliffe today. According to TipRank...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-fisher-paykel-healthcare-corporation-limited-fspkf-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-fisher-paykel-healthcare-corporation-limited-fspkf-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FPH.NZ","BK4588","BK8004","FSPKF","BK4082","XLV","LABU","XBI","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558859","title":"Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558859?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:07","pubTimestamp":1788988020,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to inflation and fuel costs.Tyra Biosciences fell sharply after the performance of a bladder-cancer drug candidate in a mid-stage clinical trial disappointed investors.Johnson & Johnson, which is also developing a bladder-cancer treatment, fell slightly.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","XLV","BK4581","JNJ","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304145","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304145","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304145?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:50","pubTimestamp":1788987000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1107 ET - Recent clinical-trial setbacks mean Novartis needs to ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","XLV","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666766537","title":"Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666766537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666766537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984060,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Sept.  09, 2026  -- Oruka Therapeutics, Inc.  , a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis and hidradenitis suppurativa, today announced its attendance at the 2026 Morgan Stanley Global Healthcare Conference, taking place in New York, NY from September 14-16, 2026.About Oruka TherapeuticsOruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from inflammatory diseases like plaque psoriasis and hidradenitis suppurativa the greatest possible freedom from their condition by achieving high rates of disease clearance with dosing as infrequently as once or twice a year. For more information, visit www.orukatx.com and follow Oruka on LinkedIn. Investor Contact:Alan Lada-606-7911alan.lada@orukatx.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3359049/0/en/oruka-therapeutics-to-attend-the-2026-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2133065610.SGD","XBI","LU1989772840.SGD","IAI","LU1668664300.SGD","LU0320765646.SGD","IE00B3S45H60.SGD","LU1732799900.SGD","LU0882574139.USD","HCSG","LU1791710582.SGD","LU0098860793.USD","LU2028103732.USD","LU1064131342.USD","LU0795875086.SGD","LU0128526141.USD","LU0795875169.SGD","IE00BZ1G4Q59.USD","BK4539","LU2089284900.SGD","LU0528227936.USD","BK4137","BK4007","BK4139","BK4588","KBWB","LU0557290698.USD","LU0158827781.USD","BK4504","LU0106261372.USD","LU1244550577.SGD","LU2487616109.SGD","BK4581","BK4534","BK4516","LU0006306889.USD","LU0912757837.SGD","LU2347655156.SGD","LU1548497426.USD","LU2089283258.USD","LENZ","LU2271345857.HKD","IE00BKVL7J92.USD","LU0971096721.USD","LU1162221912.USD","LABU","LU0390134368.USD","XLV","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537973","title":"COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537973","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537973?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:55","pubTimestamp":1788983722,"startTime":"0","endTime":"0","summary":"COMPASS Pathways, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital reit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4585","LABU","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858537","title":"Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858537","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:55","pubTimestamp":1788980100,"startTime":"0","endTime":"0","summary":"Bayer received accelerated approval from the Food and Drug Administration for its treatment of non-small cell lung cancer.The FDA approved sevabertinib as a first-line treatment for patients with adva","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BAYRY","BK4007","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666162532","title":"Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666162532","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666162532?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:08","pubTimestamp":1788977280,"startTime":"0","endTime":"0","summary":"Shares of Opus Genetics, which focuses on inherited retinal diseases, reached a 52-week high as it reported favorable drug study data and a successful meeting with the Food and Drug Administration.The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IRD","BK4007","PRGS","BK4097","LU2065732104.USD","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666453414","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666453414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666453414?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:04","pubTimestamp":1788973486,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each shedding 0.4%.The iShares Biotechnology ETF  decreased 0.7%.In corporate news, UnitedHealth  sold an interest in some of its Optum Health operations in Florida to TPG , Bloomberg reported. UnitedHealth shares were down 1.8%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU0345770993.USD","LU0149725797.USD","LU0234572021.USD","LU0353189763.USD","LU0345770308.USD","LU2491049909.HKD","SG9999002224.SGD","LU1037948541.HKD","LU1670627923.USD","LU2361045086.USD","LU2361044865.SGD","LU2125154935.USD","IE00B1BXHZ80.USD","SG9999013999.USD","IE0004445239.USD","LU1084165304.USD","LU0077335932.USD","LU1732799900.SGD","LU1791710400.SGD","IE00B775H168.HKD","LU2362540622.SGD","LU1291159041.SGD","IE00BN29S564.USD","LU0456855351.SGD","SG9999017495.SGD","LU2279689827.SGD","SGXZ51526630.SGD","LU0708994859.HKD","VHT","LU2552382132.HKD","LU0417517546.SGD","LU1261432733.SGD","LU2211815571.USD","LU0266013472.USD","LU0965508806.USD","IHF","LU1934455863.HKD","LU0553294199.USD","LU2491050071.SGD","LU0949170772.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0109391861.USD","XLV","LU1548497426.USD","LU2361044949.HKD","LU2236285917.USD","LU0238689110.USD","LU1814569148.SGD","LU2089284900.SGD","LU0316494557.USD","LU0342679015.USD","IE00BKPKM429.USD","IE00BKVL7J92.USD","IXJ","LU1323610961.USD","LU1506573853.SGD","UNH","LU1989771016.USD","LU0689472784.USD","IE00BZ1G4Q59.USD","LU0310800379.SGD","LU2362541273.HKD","LU0320765059.SGD","LU0289739699.SGD","IE000M9KFDE8.USD","IE00B1XK9C88.USD","LU0158827781.USD","HRTS","IE00B2B36J28.USD","IE00B19Z8W00.USD","LU0354030511.USD","LU0820561818.USD","LU2111349929.HKD","IE00BJJMRZ35.SGD","LU0353189680.USD","LU0053666078.USD","LU0143551892.USD","LU0052756011.USD","LU0198837287.USD","XBI","LU1551013425.SGD","LU1934455194.USD","LU2089984988.USD","MHIP","IE00BJJMRY28.SGD","LU0496365809.HKD","LU0708995401.HKD","LU0861579265.USD","IE00BSNM7G36.USD","LU0211326755.USD","LU1035773651.USD","UNHU","BK4533","LABU","LU0114720955.EUR","LU0097036916.USD","LU0661504455.SGD","LU1914381329.SGD","BK4534","IE00B19Z9Z06.USD","LU0354030438.USD","LU1074936037.SGD","LU0965509101.SGD","SG9999014906.USD","LU1066053197.SGD","LU2087625088.SGD","LU0310799852.SGD","LU2244417387.USD","IE00BFXG1179.USD","BK4581","LU0738911758.USD","LU2028103732.USD","LU2133065610.SGD","LU2242649171.HKD","UNHG","LU1983299246.USD","SG9999001176.SGD","LU1496350502.SGD","IYH","IE00B19Z8X17.USD","LU1119994496.HKD","LU0943347566.SGD","LU1066051811.HKD","IE00B19Z9505.USD","LU0310800965.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","LU1988902786.USD","LU0256863811.USD","IE00B7SZLL34.SGD","TRUH","LU0079474960.USD","LU1551013342.USD","LU1061106388.HKD","LU1778281490.HKD","LU1720051017.SGD","LU0158827948.USD","LU0912757837.SGD","LU2417539215.USD","IE0002141913.USD","IE0005OL40V9.USD","LU2999663052.SGD","LU2360032135.SGD","LU1267930490.SGD","IE00BJJMRX11.SGD","LU0823416689.USD","LU0965509283.SGD","LU1023059063.AUD","LU2456880835.USD","LU0545039389.USD","SG9999014914.USD","LU0107464264.USD","LU0683600562.USD","LU2552382215.SGD","LU0820562030.AUD","LU0128525929.USD","SG9999018857.SGD","LU0048584097.USD","LU0787776722.HKD","IE0004445015.USD","IE00B19Z9P08.USD","IE00B19Z3B42.SGD","IE00B894F039.SGD","LU0965509010.AUD","LU1064131342.USD","FHLC","LU1003077747.HKD","LU1069347547.HKD","LU1720051108.HKD","LU2357305700.SGD","LU1674673428.USD","LU2461242641.AUD","LU2954938101.SGD","LU2362541513.USD","BK4588","LU0058720904.USD","LU2347655156.SGD","LU1153585028.USD","IE00BWXC8680.SGD","BK4585","LU1057294990.SGD","LU1267930227.SGD","LU2324357040.USD","LU0162691827.USD","IE00B3T34201.USD","LU1037948897.HKD","LU1934455277.USD","SG9999018865.SGD","LU1267930730.SGD","BK4532","LU2468319806.SGD","LU2264538146.SGD","GDOC","LU0820561909.HKD","SGXZ57979304.SGD","LU1674673691.USD","LU1854104046.USD","LU0211327993.USD","LU2491050154.USD","TMED","LU2023251221.USD","LU1267930573.SGD","LU0557290698.USD","IE00BFSS8Q28.SGD","LU1732800096.USD","LU2125154778.USD","LU0072461881.USD","SUNH0main","SG9999002232.USD","SG9999014898.SGD","UN","LU1854103824.USD","LU0203345920.USD","LU1066051498.USD","LU0976567544.SGD","LU0203347892.USD","UNHW","LU0672654240.SGD","LU0251132253.USD","LU2552382058.USD","LU0795875086.SGD","LU1791710582.SGD","IE00B7KXQ091.USD","LU0211326839.USD","IE00B19Z3581.USD","JDOC","SGXZ31699556.SGD","LU1066051225.USD","IE00B4JS1V06.HKD","BK4154","LU1718418525.SGD","SGXZ81514606.USD","LU0011850046.USD","LU0029864427.USD","LU0128525689.USD","LU1670628061.USD","LU0882574055.USD","LU0795875169.SGD","LU2089283258.USD","IE00BFSS7M15.SGD","BK4566","LU0122379950.USD","LU0528227936.USD","LU0187121727.USD","LU0094547139.USD","SGXZ99366536.SGD","LU2271345857.HKD","LU0211328371.USD","SG9999014880.SGD","SG9999001176.USD","LU2112291526.USD","IE00BZ9MQY76.HKD","LU2462591277.SGD","RXL","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534635","title":"Worldwide Healthcare Trust Tightens Capital Base With Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534635","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666534635?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:20","pubTimestamp":1788970843,"startTime":"0","endTime":"0","summary":"An announcement from Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) is now available. Worldwide Healthcare Trust PLC has undertaken a market purc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LU0029874061.USD","LABU","XBI","BK4137","HCSG","XLV","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666345975","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666345975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666345975?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:20","pubTimestamp":1788970800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1107 ET - Recent clinical-trial setbacks mean Novartis needs to ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","BK4581","BK4588","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666053135","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666053135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666053135?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:10","pubTimestamp":1788966623,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pyxis Oncology (PYXS) and Opus Genetics (IRD). Pyxis Oncology (PY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","BK4137","BK4585","LU0128526141.USD","PY","LABU","XBI","LU0029874061.USD","XLV","BK4007","IRD","BK4588","PYXS","HCSG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":1,"totalSize":412,"code":"91000000","status":"200"}]}}